Medios AG Acquires Majority Stake in Caelo, Expanding European Operations

Berlin-based Medios AG has announced the acquisition of a 74% stake in Caesar & Loretz GmbH (Caelo), pending antitrust approval. Caelo, headquartered in Hilden, is a major supplier of active pharmaceutical ingredients (APIs), excipients, and raw materials. The acquisition will not affect Medios' 2026 Group forecast.

With this acquisition, Medios aims to enhance its offerings to pharmacies by integrating Caelo's long-established expertise and its own distribution network. Both companies uphold high standards of quality and reliability, crucial for patient care.

Caelo will serve as a German anchor in Medios' European network, alongside subsidiaries in Belgium and Spain, under the Medios Holding Compounding Essentials GmbH. This will create opportunities for cross-border trade of APIs under the common European GMP standard.